Evidence map›Paper›PMID 25185575›Full record

ReviewClinical and vaccine immunology : CVI2014

Gastrointestinal tract and the mucosal macrophage reservoir in HIV infection.

Dallas Brown, Joseph J Mattapallil

Abstract readReview
In one paragraph

Review in Clinical and vaccine immunology : CVI, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Delivering CRISPR to the HIV-1 reservoirs.Frontiers in microbiology · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dallas BrownUniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Joseph J MattapallilUniformed Services University of the Health Sciences, Bethesda, Maryland, USA joseph.mattapallil@usuhs.edu.

Funding

Mucosal immunity and rectal challengeR01DE019397 · NIDCR · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MATTAPALLIL, JOSEPH JOHN · 2009 to 2011
$2.4M
NIDCR NIH HHS DE019397NIDCR NIH HHS R01 DE019397
6 · The paper itself

Abstract

The gastrointestinal tract (GIT) is a primary site for human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection, replication, and dissemination. After an initial explosive phase of infection, HIV establishes latency. In addition to CD4 T cells, macrophages are readily infected, which can persist for long periods of time. Though macrophages at various systemic sites are infected, those present in the GIT constitute a major cellular reservoir due to the abundance of these cells at mucosal sites. Here, we review some of the important findings regarding what is known about the macrophage reservoir in the gut and explore potential approaches being pursued in the field to reduce this reservoir. The development of strategies that can lead to a functional cure will need to incorporate approaches that can eradicate the macrophage reservoir in the GIT.

Indexed as

Virus LatencyVirus ReplicationAntiviral AgentsGastrointestinal TractHIVHIV InfectionsHumansMacrophagesAntiviral Agents

Identifiers

PMID25185575
PMCPMC4248758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.